/Head’s Up Blog!/

Dr. Hutchinson’s Trip To India

As many of you are aware, I was asked to go to India with a team of international headache experts to educate local providers. Each one of us on the team had a specific purpose and for me, it was to focus on the treatment of migraine in women. The need for good migraine management in India is great. With a population of over 1.3 billion, the estimated prevalence of migraine in India is over 150,000 million. By comparison, the prevalence of migraine in the United States is 38 million.

2019-04-01T20:51:50+00:00April 1st, 2019|News|

Ajovy Webcast Summary

Dr. Susan Hutchinson joined Dr. Jack Schim for a live Webcast on Thursday evening, October 25th, to discuss Ajovy, the second CGRP monoclonal Antibody approved for migraine prevention. It is an injection and offers the option of quarterly or monthly dosing.

2018-11-01T17:05:21+00:00November 1st, 2018|News|

Dr. Hutchinson 2nd Author On An Abstract Titled “Patterns and Characterization of Acute Prescription Headache Medication Use: Results from the CaMEO study”

Dr. Hutchinson was 2nd author on an abstract titled "Patterns and Characterization of Acute Prescription Headache Medication Use: Results from the CaMEO study" that was accepted as a poster presentation both at the recent American Headache Society Scientific Symposium in June 2018 and at the Diamond Headache Clinic Research & Educational Foundation in July 2018.

2018-07-16T21:04:18+00:00July 16th, 2018|News|

Annual John Graham Lecture Award Winner Thanks Dr. Hutchinson Among Others

Professor Gretchen Tietjen recently received the annual John Graham lecture award from Paul Rizzoli and thanked friends and collaborators including Lynne Osborn Geweke, Dawn Buse, Sheena K. Aurora and Susan Lynn Hutchinson. "I am so happy for Dr. Gretchen Tietjen to receive this prestigious award. I was happy to be part of our Women's Issues [...]

2017-06-14T18:32:23+00:00June 14th, 2017|News|

What’s New For Migraine Prevention?

A new category of medication for prevention of migraine is in the late stages of clinical trials and is expected to be available by early 2018. This category is called CGRP Monoclonal Antibodies.

2017-03-23T14:27:01+00:00March 23rd, 2017|Tips|

Dr. Susan Hutchinson Featured In FREE Live Online Migraine Event, Register Now!

The Migraine World Summit returns this April 23 – 29, 2017 to bring together over 30 top experts and doctors to provide answers, new treatments, research and best practices for migraine and chronic headache. It's available to anyone with an internet connection. Dr. Susan Hutchinson is one of the featured specialists. The Migraine World Summit returns this April 23 – 29, 2017 to bring together over 30 top experts and doctors to provide answers, new treatments, research and best practices for migraine and chronic headache. It's available to anyone with an internet connection. Dr. Susan Hutchinson is one of the featured specialists. Register for FREE now by clicking here.

2017-05-26T22:48:45+00:00March 8th, 2017|News|

Alternatives to the Emergency Room

When a severe migraine hits, many sufferers end up in the Emergency Room (ER). This is not ideal for many reasons including the long wait to be seen, the noise and bright lights in the ER, the attitude of the ER staff often treating the migraine patient as a narcotic seeker, and lastly, the cost. There are several alternatives to the ER including an urgent care center, home rescue, or an infusion center

2017-01-09T15:21:15+00:00January 9th, 2017|Tips|